First International Workshop on Lung Cancer: Prognostic and predictive factors

First International Workshop on Lung Cancer: Prognostic and predictive factors

Lung Cancer 30 (2000) 215 www.elsevier.nl/locate/lungcan Meeting report First International Workshop on Lung Cancer: Prognostic and predictive factor...

33KB Sizes 0 Downloads 20 Views

Lung Cancer 30 (2000) 215 www.elsevier.nl/locate/lungcan

Meeting report First International Workshop on Lung Cancer: Prognostic and predictive factors June 17–19, 1999, Athens, Greece

Lung cancer is one of the most common malignancies in the world and remains the leading cause of cancer-related deaths in developed countries. The incidence is increasing especially among women. Non-small cell lung cancer accounts for almost 80% of all lung cancer cases with the rest being small cell lung cancer. Although treatment has been more effective during the last years than in the past in advanced disease, the vast majority of patients die of their disease. Intense research has been undertaken during recent years to identify prognostic factors that can isolate subgroups of patients with lung cancer with different clinical outcomes. Also, to identify factors to predict the response to different modes of treatment. In spite of many articles written, nothing is clear regarding prognosis and prediction on lung cancer. It was therefore timely to take the opportunity to get together the opinion leaders and experts around the world to clarify and reach consensus on the present status and to establish the future

direction of the prognostic and predictive factors in lung cancer. The structure of the meeting had been designed in such a way as to discuss separately small cell lung cancer and non-small cell lung cancer with focus on surgery, radiotherapy and chemotherapy. Altogether 68 investigators from 12 countries participated in the meeting, which resulted in fruitful discussions dealing with various aspects of predictive and prognostic factors ranging from their relation to molecular markers, to demographics of patients and choice of treatment. The abstract book with 29 contributions can be obtained from the organizers of the meeting Paris A. Kosmidis Medical Oncology Department, ‘Hygeia’ Hospital, 2 An. Tsoka & Vas. Sofias A6en, 11521 Athens, Greece

.

0169-5002/00/$ - see front matter © 2000 Elsevier Science Ireland Ltd. All rights reserved. PII: S 0 1 6 9 - 5 0 0 2 ( 0 0 ) 0 0 1 3 8 - 0